India’s political-bureaucratic failure to unleash economic reforms with sustained momentum is the single-biggest ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Charles River Laboratories (NYSE:CRL) lost ~12% in the premarket on Tuesday after the contract research organization said its 2025 revenue on an organic basis is expected to decline at a similar ...

Informing the Indian stock market exchanges about the Q3 results 2025 schedule, Infosys said, "Infosys (NSE, BSE, NYSE: INFY), a global leader in next-generation digital services and consulting ...

Infosys Q3 Results: Infosys announced its October-December quarter results for fiscal 2024-25 (Q3FY25) on Thursday, January 16, 2025, reporting an attrition rate of 13.7 per cent, compared to 12.9 ...

Infosys Share Price Today Live Updates, 16 Jan, 2025: SMA and EMA Trends: Insights into Infosys' Market Performance Infosys' latest moving averages reveal key trends across various time frames ...

Infosys share price today, January 17: The company’s net profit came in at Rs 6806 crore, up 11.46% year-on-year. (Image: Infosys/website) Infosys shares plunged as much as 5.8% to an intra-day ...

Infosys has escalated its legal battle against Cognizant by filing a counterclaim accusing Cognizant and CEO Ravi Kumar of anti-competitive tactics to hinder its Helix healthcare platform.